Better late than never: AstraZeneca finally pushes potassium drug Lokelma to the FDA finish line

Third time's the charm for AstraZeneca’s blockbuster hopeful Lokelma, formerly known as ZS-9—and known for its two-in-a-row rejections on manufacturing shortfalls. With an FDA approval in…
Read the full story: FiercePharma: Pharma